Participants 64 112 4
the LIPID Trial for Secondary Prevention of IHD.
Participants 393 487 8
patients with a previous myocardial infarction or unstable angina-ischemic heart disease (IHD)
Participants 539 597 6
9014 patients from 85 centers in Australia and New Zealand
